Pay in 4 interest-free payments of $48.00 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Bortezomib is the first proteasome inhibitor anticancer agent
Processed IL-38-activated IL1RAPL1 reduces the production of IL-6 leading to inflammation attenuation
Q-VD-OPh is an irreversible pan-caspase inhibitor with potent antiapoptotic properties
The urinary RBP4 concentration may be a valuable marker for both
Unlike a resin-based depletion kit (that only deals with microliter amounts of a sample)
Itraconazole Pack Size:500 mg Bortezomib is the first proteasomeItraconazole (R51211) is a triazole antifungal agent and a potent and orally active Hedgehog (Hh) signaling pathway antagonist with an IC50 of ~800 nM. Itraconazole potently inhibits lanosterol 14 demethylase (cytochrome P450 enzyme), thereby inhibits the oxidative conversion of lanosterol to ergosterol. Itraconazole has anticancer and antiangiogenic effects. Itraconazole is a oxysterol binding protein (OSBP) inhibitor.
US$ 170.00
US$ 50.99
US$ 39.00
US$ 120.00
US$ 74.99
US$ 54.99
US$ 49.50
US$ 49.50
US$ 115.00
US$ 159.99
US$ 84.00
US$ 175.00
US$ 30.00
US$ 130.00
US$ 160.00